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Cyprinid  herpesvirus-3  (CyHV-3)  is  an  etiological  agent  of a  notiﬁable  disease  that  causes  high  mortality
rates  affecting  both  the  common  and  koi  carp  Cyprinus  carpio  L. There  is  no current  treatment  strat-
egy  to save  CyHV-3  infected  ﬁsh.  RNA  mediated  interference  (RNAi)  is  an  emerging  strategy  used  for
understanding  gene  function  and  is  a promising  method  in  developing  novel  therapeutics  and  antiviral
medications.  For  this  study,  the  possibility  of  activating  the RNAi  pathway  by  the  use  of  small  interfering




siRNAs  were  designed  to  target  either  thymidine  kinase  (TK)  or DNA  polymerase  (DP)  genes,  which  both
code for  transcripts  involved  in  DNA  replication.  The  inhibition  of viral  replication  caused  by the siRNAs
was  measured  by  a reporter  gene,  termed  ORF81.  Treatment  with  siRNA  targeting  either TK  or  DP  genes
reduced  the  release  of viral  particles  from  infected  CCB  cells.  However,  siRNA  targeting  DP was most
effective  at  reducing  viral  release  as  measured  by  qPCR.
ublis©  2014  The  Authors.  P
Cyprinid herpesvirus-3 (CyHV-3) is an etiological agent of a noti-
able disease that causes high mortality rates (80–100%) affecting
oth the common and koi carp Cyprinus carpio L. (Hedrick et al.,
000; Ilouze et al., 2006). Outbreaks of this virus were reported in
urope (Bretzinger et al., 1999), US and Israel (Hedrick et al., 2000),
s well as in South East Asia (Sano et al., 2004; Kurita et al., 2009;
an et al., 2013). Two different prophylactic strategies have been
eveloped for protection against CyHV-3: (1) a brief exposure to
he virus, followed by transferring infected ﬁsh to non-permissive
emperature (30 ◦C) or (2) infection with a live attenuated CyHV-3
Ronen et al., 2003; Perelberg et al., 2005). However, recent studies
ndicate that survivors of CyHV-3 infection can become carriers for
he disease (St-Hilaire et al., 2005; Bergmann and Kempter, 2011;
ide et al., 2011). There is no current treatment for CyHV-3 infected
sh.
RNA mediated interference (RNAi) is an emerging strategy used
or understanding gene function and is a promising method in
eveloping novel therapeutics and antiviral medications (Gavrilov
nd Saltzman, 2012). RNAi based therapeutics have been suggested
or the development of novel therapies against viral diseases and
arasitic agents of aquatic organisms (Lima et al., 2013). Recent
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in vitro (Sarathi et al., 2008) and in vivo (Sarathi et al., 2010) stud-
ies have demonstrated promising results for using RNAi to combat
white spot syndrome virus (WSSV), which is an aquatic viral dis-
ease of shrimp. Similarly, several in vitro (Ruiz et al., 2009; Kim and
Kim, 2011; Kim et al., 2012) and in vivo (Schyth et al., 2007, 2012;
Bohle et al., 2011) studies have tested controlling a ﬁsh viral dis-
ease, termed viral hemorrhagic septicemia virus (VHSV), by RNAi.
For this study, the feasibility of using short double stranded RNAs
termed small interfering (si)RNAs was tested to inhibit in vitro viral
replication of CyHV-3. The siRNAs target either thymidine kinase
(TK) or DNA polymerase (DP) genes, which both code for transcripts
involved in DNA replication and are regulated differentially when
CyHV-3 infected common carp brain (CCB) cells are subjected to
non-permissive temperature (Dishon et al., 2007).
A new primer set was designed to measure the release of CyHV-3
from infected cells based on a component of the viral envelope (gly-
coprotein ORF81), one of the earliest characterized CyHV-3 proteins
(Rosenkranz et al., 2008). The 771 bp coding sequence of CyHV-3
ORF81, GenBank access number JQ308818.1, Gene ID: 382929299
was cloned into pET100 (Life Technologies, Wien, Austria). The vec-
tor was digested with ScaI (Promega, Wien, Austria) and subjected
to a series of 10-fold dilutions starting with 1 ng/l of plasmid DNA.
A standard curve for a primer set targeting ORF81 (Table 1A) was
tested for detection of CyHV-3 by TaqMan hydrolysis quantitative
(qPCR) and showed the primers to be efﬁcient for quantitation of
the virus (Fig. 1). The siRNAs to target CyHV-3-U thymidine kinase
gene, GenBank access number AB375385.1, Gene ID: 241661587
nder the CC BY license (http://creativecommons.org/licenses/by/3.0/).
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Table 1
Sequence list (A): primer and probe set targeting the CyHV-3 ORF81 gene (GenBank access number JQ308818, Gene ID: 382929299) used to quantitate CyHV-3 by qPCR.
(B):  CyHV-3 speciﬁc siRNAs target CyHV-3 thymidine kinase (TK) gene (GenBank access number AB375385, Gene ID: 241661587) and DNA polymerase (DP) gene (GenBank
access number AY939862, Gene ID: 61696088). (C): Control siRNAs target Spring Viremia of Carp (SVC) virus, nucleoprotein (N) gene (GenBank access number NC 002803,
Gene  ID: 921324).
Name Targeted gene Description Sequence
A
ORF81-FP ORF81 Forward primer TGCTGTGTTGCTTGCACTTATYT
ORF81-RP ORF81 Reverse primer TCAAACKAARGACCGCATTTCG
ORF81-PR ORF81 Probe FAM-ATGAAGARGAGTAAACKGCCTGCAACAGA-BHQ1
B
DP  DNA polymerase Forward siRNA CCUCUACAACGUGCACUUUTT
DP  DNA polymerase Compliment siRNA AAAGUGCACGUUGUAGAGGTT
DP  DNA polymerase Gene target CCTCTACAACGTGCACTTT
TK  Thymidine kinase Forward siRNA UCGACGAGGGACAGUUCUUTT
TK  Thymidine kinase Compliment siRNA AAGAACUGUCCCUCGUCGATT
C
TK  Thymidine kinase Gene target TCGACGAGGGACAGTTCTT
































SVCV-N Nucleoprotein Gene ta
nd DNA polymerase gene, GenBank access number AY939862.1,
ene ID: 61696088 were designed using Block-iT RNAi Designer
Invitrogen, Wien, Austria), and synthesized by Ambion (Invitro-
en) to carry dTdT 3′ overhangs (Table 1B). In addition, siRNAs
argeting non-CyHV-3 genes, but a gene in spring viremia of carp
irus (SVCV) was used as a control (Table 1C). Duplexes were
esuspended in DEPC-treated water to obtain 20 M (0.266 g/l)
olutions and aliquoted for use.
CCB-816 cells were propagated in ZB4G medium: MEM  Earle’s
alts 880 ml/L (Invitrogen), l-Glutamine 200 mM (Invitrogen)
0 ml/L, Gibco non-essential amino acids 10 ml/L (Invitrogen), with
0% per volume fetal bovine serum (FBS) and antibiotic/antimycotic
ix  (Sigma–Aldrich, Vienna, Austria). Two days after seeding CCB
ells into fresh 24-well plates, a 100 l aliquot of CyHV-3 at 103.39
CID50/ml was added to each plate and incubated at 22 ◦C. The
ext day, siRNA aliquots were added according to the manufac-
urer’s instructions into duplicate wells in the previously prepared
4-well plate. Brieﬂy, siRNA aliquots were resuspended in 100 l
pti-mem® I reduced-serum medium liquid (Invitrogen) and incu-
ated with 1 l Lipofectaimine® LTX reagent (Invitrogen) at room
emperature for 30 min  and appropriate aliquots were applied
mmediately into individual wells. On the next day, 24 h post
ddition of siRNAs, the medium was replaced. Six days later, the
edium from each plate was collected to be used for quantitation of
iral release by qPCR. DNA was extracted from 200 l supernatant
ractions using the DNeasy Blood and Tissue kit (Qiagen, Hilden,
ermany). DNA expression was measured in duplicates using qPCR
ig. 1. Standard curve for quantitation of ORF81. (A) TaqMan hydrolysis qPCR primer se
eries  begins with the equivalent of 7.10 × 108 viral particles which is detected below the
hich  is detected near the 40th Cq. The ﬁnal dilution lacks a duplicate, indicated by #.iRNA UUGUGUCCGAAGCUAUCCCTT
GGGATAGCTTCGGACACAA
using the CFX real-time system attached to a C100 Touch ther-
mal  cycler (Bio-Rad, Vienna, Austria). For treatment with siRNAs
targeting CyHV-3, except for treatment with 3 l TK, there was
a correlative effect for the quantity of siRNA treatment targeting
either TK or DP and reduction of viral release as measured by qPCR
compared to control siRNAs (Fig. 2). Treatment with a ﬁnal concen-
tration of 60 nM (3 l) of siRNAs targeting DP was more effective at
reducing virus release than the equivalent treatment targeting TK
(3 l), or a cumulative ﬁnal concentration for both siRNAS of 60 nM
provided by treatment with 1.5 l DP and 1.5 l TK (Fig. 2d).
The 295 kb genome of CyHV-3 codes for 156 open reading
frames (Aoki et al., 2007) and the relative transcriptional timing
for each gene has been annotated (Ilouze et al., 2012). Michel et al.
(2010) have elucidated 40 of the CyHV-3 proteins incorporated into
mature virons. Several recent studies addressed the host–pathogen
interactions of CyHV-3 on the protein level (Gotesman et al., 2013a,
2013b; Ouyang et al., 2013) or on the transcriptional level (Adamek
et al., 2012, 2013; Rakus et al., 2012). Infectious CyHV-3 mate-
rial remains persistent in the natural environmental (Minamoto
et al., 2011) and factors such as feeding (Kielpinski et al., 2010),
mating (Uchii et al., 2011) or high stocking density (Dishon et al.,
2005) exacerbate conditions for CyHV-3 outbreaks. The only cur-
rently acceptable measure for the control of CyHV-3 outbreaks is
depopulation (eradication of the infected and exposed ﬁsh) and dis-
infection of all materials and systems that have been in contact with
infected ﬁsh. The purpose of this study was  to test the feasibility of
using RNAi as an alternative strategy to save CyHV-3 infected ﬁsh.
t targeting ORF81 was established for quantitation of the CyHV-3. (B) The dilution
 13th curve threshold (Cq) and ends with the equivalent of 7.10 × 100 viral particles
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2ig. 2. Inhibition of viral replication. For ﬁgures (A–D), Taqman qPCR was used to m
f  ORF81 as compared to the sample with 3 l control siRNA treatment (siRNACo3
 thymidine kinase (TK) as described in the text. The volume 1 l is equivalent to 
0  M (0.798 g/l) of siRNA duplexes.
he machinery for RNAi is presumed to have developed naturally as
 defensive mechanism against viruses and transposable elements
Obbard et al., 2009). Fire et al. (1998) ﬁrst demonstrated that the
NAi pathway is induced by double stranded RNA. In this study,
hort double stranded RNA that targets CyHV-3 genes involved in
NA synthesis was tested to inhibit viral release in CCB cells.
Earlier PCR protocols for detection (Gilad et al., 2002; Bercovier
t al., 2005) or quantitation (Gilad et al., 2004; Yuasa et al., 2012)
f CyHV-3 were developed based on the ampliﬁcation of regions
hat either lacked a biologically deﬁned function or on the TK gene.
or this study, a new qPCR protocol was developed to measure the
elease of viral particles from CCB infected cells for a gene (ORF81)
ith a biologically deﬁned function which was not targeted by the
iRNA. Previous ﬁndings in TK deletions reported no signiﬁcant dif-
erences for in vitro replication of CyHV-3 compared to wild-type
irus (Costes et al., 2008; Fuchs et al., 2011). However, differences
n mortality rates were observed in the CyHV-3 TK deletion strain
uring an in vivo trial (Costes et al., 2008). The disparity from those
rials can lead one to speculate that although attenuation of CyHV-3
n the TK deletion strain can be observed in vivo by lower mortality
ates, it may  have been overlooked in vitro because both aforemen-
ioned studies measured virus titer by endpoint titration. In this
tudy, viral replication was measured by qPCR, which is a sensitive
uantitation tool that recognizes ﬁne difference in copy number.
n our study we were able to observe differences of viral parti-
le release by siRNA inhibition of both TK and DP as compared
o control siRNA in CyHV-3 infected CCB cells. The subtle differ-
nces detected by qPCR may  explain differential in vivo survival
ates observed in TK deletions (Costes et al., 2008). The siRNAs used
n this trial were unmodiﬁed and are known to be effective for a
imited time after transfection (Schyth et al., 2012). The transient
ature of siRNA inhibition can be enhanced by chemical modiﬁ-
ations to siRNAs (Schyth et al., 2012) or the use of longer dsRNA
27/25 mer) that are cellular substrate targets for dicer (Bohle et al.,
011).e the inhibition of viral replication. The y-axis refers to relative gene copy number
x-axis refers to the volume and type of siRNA administered, DNA polymerase (DP)
 (0.266 g/l), 2 l is equivalent to 40 M (0.532 g/l), and 3 l is equivalent to
For this study, siRNA was designed to target two genes involved
in DNA replication (TK and DP) and the inhibition of viral repli-
cation caused by the siRNAs was  measured by a reporter gene
(ORF81) all of which are considered early genes that are tran-
scribed in the ﬁrst 2–4 h after CyHV-3 infection in CCB cells (Ilouze
et al., 2012). Although the statistical signiﬁcance was  not explicitly
calculated for the effectiveness of each siRNA, experiments per-
formed in triplicate showed that treatment with siRNA targeting
either TK or DP genes signiﬁcantly reduced the release of viral par-
ticles from infected CCB cells (Fig. 2). However, siRNA targeting DP
was most effective at reducing viral release as measured by qPCR
of ORF81. This preliminary trial with siRNA establishes the basis
for using RNAi technology, preferably more stable forms such as
long dsRNA that target the entire DP transcript, to control CyHV-3.
Further in vivo trials should be performed to determine whether
RNAi-based therapeutics can be used to protect ﬁsh from CyHV-3.
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